ABSTRACT
H
ereditary hemorrhagic telangiectasia (HHT) or Rendu-Weber-Osler disease is a familial disorder that occurs with a prevalence of approximately 1/10,000. [1] [2] [3] The diagnostic certainty of HHT is determined by the number of characteristic clinical findings present in an individual patient. These clinical findings are the following: 1) nosebleeds, 2) mucocutaneous telangiectasias (of the lips, oral cavity, nose, or fingers), 3) AVMs (of the lungs, the gastrointestinal system, or the CNS), and 4) an affected first-degree relative. In "definite" HHT, 3 of these clinical criteria are present, while "suspected" or "unlikely" HHT diagnoses consist of 2 or 1 item present, respectively. It is estimated that 10%-20% of patients with HHT have brain vascular malformations 4 with additional neurovascular complications from pulmonary AVMs (stroke and cerebral abscess). 5 HHT is inherited as an autosomal dominant disorder, caused by mutation in 1 of 3 genes identified to date: endoglin (HHT1) on chromosome 9q34; activin receptor-like kinase 1 or ALK1 (HHT2) on chromosome 12q13; and SMAD4 on chromosome 18q21 (juvenile polyposis, HHT overlap syndrome). [6] [7] [8] [9] [10] The associated gene products are expressed in endothelial cells and are part of the transforming growth factor-␤ signaling pathway, thus involved in angiogenesis and vascular remodeling. Endothelial cells lacking functioning endoglin or ALK1 form abnormal vessels and abnormal connections between vessels. 6 Early HHT genotype-phenotype correlation studies demonstrated an association between endoglin mutation and brain AVMs, [11] [12] [13] though more recent studies have demonstrated that brain AVMs can be present with all HHT genotypes. 14, 15 No studies to date have addressed HHT brain AVM phenotypes and their correlation with genotype, to our knowledge. To date, in the 2 largest single-center series of brain AVMs in HHT with 52 and 14 patients, respectively, 3 different distinct phenotypes of brain vascular malformations were described independently: 1) high-flow "single-hole" pial fistulas, 2) "classic" nidus-type brain AVMs, and 3) "micro-AVM" or "capillary vascular malformations," defined as small lesions without clear evidence of a shunt. 5, 16 The aim of the present series was 2-fold: 1) to identify the different radiologic and, in particular angiographic features of brain vascular malformations in HHT, and to subclassify them into different types, and 2) to determine whether there is a genotype-phenotype correlation between the HHT gene mutation and the type of vascular malformation.
MATERIALS AND METHODS

Study Population
We analyzed data from patients recruited to the HHT Project of the Brain Vascular Malformation Consortium. Patients with HHT with a confirmed clinical HHT diagnosis by the Curaçao criteria 17 or a confirmed genetic diagnosis were enrolled as part of the Brain Vascular Malformation Consortium HHT Project as previously described (http://rarediseasesnetwork.epi.usf.edu/ BVMC). 18 All patients provided written, informed consent, including consent for genetic studies. The study protocol was approved by each institutional review board. Between 2010 and 2012, comprehensive data were available for 384 recruited patients with HHT, 125 of whom had brain AVMs, with sufficient diagnostic imaging available for review in 75 of these patients with brain AVMs. All patients provided written, informed consent, and the study protocol was approved by each institutional review board.
Data Collection
Epidemiologic data collected included age at enrollment and diagnosis, sex, and HHT mutation type. Radiologic data included MR imaging (with contrast-enhanced sequences in at least 2 planes on 1.5T or 3T scanners) and angiography with multiphase biplanar selective 4-vessel angiography. The angiographic parameters that were identified for every patient who was identified with a brain vascular malformation are listed in the On-line Table. In addition to location, size in the largest dimension, and eloquence (as determined by the Spetzler-Martin classification), specific information about feeding arteries (such as the degree of dilation, number, type [choroidal versus pial], associated aneurysms, and so forth), the nidus (glomus versus fistula, diffuse versus sharp, perinidal angiogenesis, and so forth), and the draining veins (associated pouches, degree of dilation, associated stenosis, number, deep versus superficial, and so forth) was noted. Images were reviewed by 2 of the authors (T.K. and S.P.) in consensus; in cases of disagreement, a third neuroradiologist (K.G.t.B.) reviewed the case.
On the basis of previous work and our observations in the present study, we were able to subclassify 3 types of vascular malformations: the pial arteriovenous fistula (defined by the absence of an intervening nidus between the feeding artery and draining vein in the presence of a shunt), the nidus-type AVM (defined by the presence of a shunt with early filling of a vein through a dilated network of abnormal vessels), and a "capillary malformation," in which no shunt was visible on angiography and no dilated feeding arteries or veins were identified; just a blush of abnormal vessels was seen in the capillary phase. Vascular malformations that did not fit into any of these categories (developmental venous anomalies, dural arteriovenous fistulas, pontine capillary telangiectasias, cavernomas, and so forth) were specifically sought and, if present, were recorded.
Statistical Tests
We tested for differences of age at diagnosis, sex, and HHT gene mutation (ALK1 versus endoglin) between patients with AVFs and those without AVFs. Similarly, we tested for differences in characteristics between patients with capillary vascular malformations (CVMs) and those without and for patients with AVMs and those without. Additionally, we checked whether age, sex, or HHT gene mutation was associated with lesion multiplicity (Ն2 lesions of any type). Comparisons involving age were tested with 2-sample t tests, allowing for unequal variances, while comparisons involving sex or mutation differences were tested by using Fisher exact tests. We considered P values Ͻ .05 to be statistically significant. All analyses were performed using STATA/SE 13.1 (StataCorp, College Station, Texas).
RESULTS
A summary of demographic and clinical features of the 75 HHT subjects with brain AVMs is presented in Table 1 . The average age at enrollment for these subjects was 37 years, and the average age at brain malformation diagnosis was 30 years. Women were slightly more prevalent in the sample (55%). HHT gene mutation status was available for 60% of participants, and among those, 60% had an endoglin mutation.
On the basis of the criteria described in the "Materials and Methods" section, we identified 3 different types of vascular malformations: capillary vascular malformations, AVMs, and AVFs. Table 2 details the distribution of these lesions across subjects. Capillary vascular malformations were the most commonly observed lesion, with 61% of subjects having Ն1 CVM. Fortythree percent of subjects had Ն1 AVM, and 12% had Ն1 AVF. One subject had a dural arteriovenous fistula, and 1 subject had a developmental venous anomaly. Multiplicity of lesions was common: Thirty-three (44%) subjects had Ն2 brain malformations.
Tables 3-5 present the typical imaging features of the different vascular malformations: CVMs were identified as lesions that had no dilated feeder and no dilated draining veins (Figs 1-3) . Eighty of these lesions were identified in 46 patients. All of these lesions were Ͻ1 cm; most were located in the superficial supratentorial brain. On MR imaging, they appeared as small foci of "fluffy" enhancement without abnormal vascular dilation. There was no edema surrounding these vascular malformations. Thirty-four AVMs were present in 32 patients (Figs 4 and 5) . As the major differentiating factor from CVMs, the AVMs had enlarged feeding arteries and draining veins and a shunt was visible on angiography. In all, an intervening nidus of abnormal vessels was identified. Lesions were almost always Ͻ3 cm and rarely (in 2 cases) Ͻ1 cm. They had a compact, well-defined nidus and were mainly located supratentorially and superficially. Given the superficial location and the small size, their Spetzler-Martin grade was typically 1-2, with the higher grades mainly driven by their potential location in eloquent cortex. Feeding arteries were almost always pial vessels (we encountered only 1 choroidal AVM in this series) and were classically fed by terminal-type feeders. Associated aneurysms or other signs for high flow (pial-to-pial collaterals, venous ectasias, and so forth) were uncommon. On the venous side, venous reflux or corkscrew-like dilated veins as signs of long-standing venous hypertension were typically absent. Eleven AVFs were present in 9 patients; these were typically high-flow single-hole macrofistulas that were located in the supratentorial superficial brain with significant venous ectasia and signs of high flow with consecutive perilesional hypoxemia (Figs 6 and 7) . We found that patients with AVFs tended to be diagnosed at younger ages than those without AVFs (P ϭ .028); the average age at diagnosis for patients with AVFs was 15 years compared with an average age of 32 years for patients without AVFs. There was no significant association between the presence of AVFs and sex (P ϭ .723) or HHT gene mutation (P ϭ 1.000). No significant difference was observed with age, sex, or HHT gene mutation in those patients with capillary vascular malformations versus no CVMs or in patients with AVMs versus those without AVMs. Lesion multiplicity was also not significantly associated with age (P ϭ .736), sex (P ϭ .484), or HHT gene mutation (P ϭ 1.000).
DISCUSSION
We report herein the largest series and most comprehensive description of brain AVM phenotype among patients with HHT.
On the basis of radiologic and angiographic information, we were able to subclassify 3 different brain vascular malformations in patients with HHT that had some common and distinctive imaging features: The common finding was that brain vascular malformations in HHT tended to be located in supratentorial and superficial compartments. Deep or infratentorial locations were atypical. This finding corresponds well with the literature: In the Bicêtre series, 61 of 68 brain vascular malformations (90%) were located superficially and 45 of 68 lesions (66%) were supratentorial. 16 Lesion identification by MR imaging was always possible for the AVMs and AVFs; however, a few capillary vascular malformations could not be detected by MR imaging alone. Distinguishing features among the 3 subtypes were the presence or absence of a shunt and, if a shunt was present, whether the abnormal arteriovenous communication was direct (ie, fistulous) or through a network (or nidus).
Pial AVFs typically had a high shunt volume and therefore often led to massive enlargement of the feeding arteries, significant venous ectasia, and, due to locoregional hypoxemia, secondary changes such as perinidal angiogenesis. We presume that the relatively higher proportion of direct fistulas in the Bicêtre series was related to a referral bias because these lesions tend to be more commonly found in children. 16 Brain AVMs in our series tended to be small (typically Ͻ3 cm in their largest diameter and, in 2 cases, Ͻ1 cm), and because their location was typically superficial, their Spetzler-Martin grade tended to be low. Again, this is in keeping with the findings in previous literature. The socalled capillary vascular malformations did not present with dilated vessels (neither on the feeding artery nor the draining venous side) and demonstrated a focal area of fluffy enhancement on MR imaging.
In this article, we introduce the term "capillary vascular malformation" for those vascular malformations that do not exhibit enlarged arteries or veins on MR imaging and in which no true shunt is present on angiography. These vascular malformations have been previously coined "micro-AVMs," which may lead to the assumption that they behave in a manner similar to true brain AVMs. However, because these vascular lesions differ from "AVMs" in their angioarchitecture, one may hypothesize that they also behave differently in their clinical presentation, an assumption that is founded on the combined experience of the Toronto 5 and the Bicêtre 16 articles, in which no hemorrhages were encountered for these types of malformations. While in AVMs an arteriovenous shunt is present due to lack of a true capillary bed, the term "capillary malformation" tries to highlight the absence of a shunt and the presence of a capillary bed that is abnormally dilated (and thus visible as a blush within the capillary phase of the angiography and faint enhancement on MR imaging).
We found, similar to findings in previous series, 20 no significant sex predilection, a rather young overall age at presentation, and a high propensity for multiplicity of brain lesions if present. Our proportion of multiplicity (33 in 75 patients ϭ 44%) was very similar to numbers reported previously (23 of 56 patients ϭ 39% in the series of Bharatha et al 20 ; 16 of 44 ϭ 36% in the Bicêtre series, when taking into account only the cerebral manifestations 16 ).
Given a rate of approximately 1% multiplicity of brain vascular malformations in the non-HHT population, our data support the previously described high predictive value of AVM multiplicity for the diagnosis of HHT.
Our observations are in keeping with previous reports on the neurovascular manifestations in HHT, but we think that proof of findings of these single-center studies from a multicenter consortium is still necessary and worthwhile reporting. To date, most studies on brain vascular malformations in HHT do not subclassify the different types of vascular malformations. However, it is quite conceivable that the various types will have different natural histories and therefore warrant different treatments. In neither of the 2 larger series that reported clinical data of the various types of brain vascular malformations in HHT were there any hemorrhages reported for patients with capillary vascular malformations. 21 Whether the rate of hemorrhage of vascular malformations associated with HHT is different from that of sporadic brain AVMs in the non-HHT population remains a matter of debate 22 : In Dutch and American HHT populations, a hemorrhagic risk of Ͻ1% was reported, 22 ,23 a risk that was deemed significantly smaller than the presumed risk of hemorrhage in the population with sporadic AVM. However, in a retrospective study of 22,061 patient-years, similar hemorrhage rates between both groups (approximately 2.0% per patient-year) were found. 24 Finally, Morgan et al 25 stated that, in particular, infants and children are at high risk of sudden intracranial hemorrhage, which was further supported by the Bicêtre series, 16 in which only 13 of the 50 patients had no symptoms attributable to their neurovascular manifestations. However, because these 2 latter studies are single-center studies, data may be biased due to referral base.
A potential problem of the large-scale population-based studies is that the type of vascular malformation was not further evaluated. It was assumed that all HHT-related brain vascular malformations be- have similarly. However, one may argue that the difference in overall bleeding rates in HHT vascular malformations compared with sporadic AVMs observed in some studies may be driven mainly by the capillary vascular malformations (ie, the most often encountered and most benign type of vascular malformation in HHT), thus biasing the results to false low rates of hemorrhage. Thus, if the presented subclassification of brain vascular malformation in HHT proves to be reflected in clinical manifestations, treatment strategies will have to be altered and individualized to the type of vascular malformation, with a more aggressive treatment in arteriovenous fistulas and/or nidus-type AVMs compared with CVMs.
HHT gene mutation information was available for 60% of our patients, and we did not observe a statistically significant association with HHT gene mutation and the type of vascular malformation or the occurrence of multiplicity. This finding fits with the clinical observation that members of the same family can present with different HHT phenotypes, though they have the same type of mutation. An important caveat of our study is that we do not have genetic information for all patients included. However, our results are also in accordance with previous reports that found brain vascular malformations to be present in all types of mutations.
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CONCLUSIONS
Our study identified several different types of brain vascular malformations in patients with HHT, which may have different natural history and treatment risks. Future studies should focus on describing the hemorrhage risks associated with these different HHT brain vascular malformations.
